This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Scheie syndrome

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Scheie syndrome is a mucopolysaccharidosis where the underling defect is deficiency of alpha-L-iduronidase. This is the same deficiency seen in Hurler's syndrome, however in Scheie syndrome it only affects dermatan sulphate, the accumulation of which in tissues is responsible for the clinical manifestations.

  • Scheie syndrome patients typically display variable clinical symptoms that can include coarse facial features, corneal clouding, cardiac valve disease, joint stiffness, clawed hands, malaise/fatigue and other somatic features
    • onset of these clinical symptoms is usually delayed compared to that in Hurler syndrome patients and the disease progression is less rapi
      • in some patients with an attenuated form of the disorder, intelligence can be normal, stature can be relatively normal and the patient can have a normal lifespan

Reference:

  1. (1) E.F. Neufeld and J. Muenzer, The mucopolysaccharidoses. In: C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle, Editors, The Metabolic Basis of Inherited Disease (7th ed.),, McGraw-Hill, New York (1995), pp. 2465-2494.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.